<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药筛 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-13T01:27:25+08:00</updated>
  <subtitle>药品筛选</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>大热ADC，创新药的“练兵场”</title>
    <updated>2020-11-12T23:23:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/bgzNSCUgwSTlk-1Z3FuEhQ</id>
    <link href="https://mp.weixin.qq.com/s/bgzNSCUgwSTlk-1Z3FuEhQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采威力太大，代理商需多留意这些品种</title>
    <updated>2020-11-10T16:58:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/cGhchSMQZRpUNdAztBC7wg</id>
    <link href="https://mp.weixin.qq.com/s/cGhchSMQZRpUNdAztBC7wg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>泮托拉唑、艾司奥美拉唑等多个重磅注射剂过评价，普瑞巴林胶囊再添新成员 | 上周仿制药动态（11.2-11.8）</title>
    <updated>2020-11-09T16:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/dEYL0bicPGkEVyoUQd45PA</id>
    <link href="https://mp.weixin.qq.com/s/dEYL0bicPGkEVyoUQd45PA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百亿PPI市场，集采后会怎样？</title>
    <updated>2020-11-05T19:36:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/uFEmgFdIARWrThLt_V9l0g</id>
    <link href="https://mp.weixin.qq.com/s/uFEmgFdIARWrThLt_V9l0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>97个品种过评，注射剂过评通道开放 | 10月仿制药动态</title>
    <updated>2020-11-04T10:17:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/HaDTF-zvPWD4cBjPRzaI2g</id>
    <link href="https://mp.weixin.qq.com/s/HaDTF-zvPWD4cBjPRzaI2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这些注射剂总销售额过千亿，离集采还有多远</title>
    <updated>2020-11-03T18:11:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/-qSuofgS1izeYzN-0upj_g</id>
    <link href="https://mp.weixin.qq.com/s/-qSuofgS1izeYzN-0upj_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注射用硼替佐米 齐鲁、豪森过评价 | 上周仿制药动态（10.26-11.1）</title>
    <updated>2020-11-02T20:32:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/iHCSmgmtkOMMDzS3n1pRUw</id>
    <link href="https://mp.weixin.qq.com/s/iHCSmgmtkOMMDzS3n1pRUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注射剂一致性评价补充申请通道打开，价格大战近在眼前</title>
    <updated>2020-10-29T18:33:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/NMaRY7psUg8SzP4X7nvq-g</id>
    <link href="https://mp.weixin.qq.com/s/NMaRY7psUg8SzP4X7nvq-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>依诺肝素、美罗培南、帕瑞昔布3个注射剂过评 | 上周仿制药动态（9.19-10.25）</title>
    <updated>2020-10-26T17:26:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/A6gvUi_dkdsqKVoPWI01FQ</id>
    <link href="https://mp.weixin.qq.com/s/A6gvUi_dkdsqKVoPWI01FQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这个最强乙肝药，还能入手不？</title>
    <updated>2020-10-24T09:03:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/8o5VUQTRaHp-hQtwXEE9nQ</id>
    <link href="https://mp.weixin.qq.com/s/8o5VUQTRaHp-hQtwXEE9nQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>